Ironwood Pharmaceuti (IRWD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 528,448 | 487,074 | 431,229 | 39,926 | 106,176 |
| Depreciation Amortization | 1,523 | 1,164 | 806 | 410 | 3,564 |
| Income taxes - deferred | -333,294 | -335,227 | -337,800 | N/A | N/A |
| Accounts receivable | 7,712 | 20,127 | 19,794 | 35,037 | 4,091 |
| Other Working Capital | 17,731 | 11,633 | 5,499 | 24,513 | -941 |
| Other Operating Activity | 39,775 | 12,556 | 2,734 | -26,192 | 55,946 |
| Operating Cash Flow | $261,895 | $197,327 | $122,262 | $73,694 | $168,836 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -265 | -137 | N/A | N/A | -1,842 |
| Investing Cash Flow | $-265 | $-137 | $N/A | $N/A | $-1,842 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 19,581 | 14,037 | 7,873 | 2,211 | 18,546 |
| Common Stock Repurchased | -24,131 | N/A | N/A | N/A | N/A |
| Financing Cash Flow | $-4,550 | $14,037 | $7,873 | $2,211 | $18,546 |
| Beginning Cash Position | 364,784 | 364,784 | 364,784 | 364,784 | 179,244 |
| End Cash Position | 621,864 | 576,011 | 494,919 | 440,689 | 364,784 |
| Net Cash Flow | $257,080 | $211,227 | $130,135 | $75,905 | $185,540 |
| Free Cash Flow | |||||
| Operating Cash Flow | 261,895 | 197,327 | 122,262 | 73,694 | 168,836 |
| Capital Expenditure | -265 | -137 | N/A | N/A | -1,842 |
| Free Cash Flow | 261,630 | 197,190 | 122,262 | 73,694 | 166,994 |